2^nd International Conference on Cytopathology & Histopathology August 10-12, 2016 Las Vegas, Nevada, USA

Sin Hang Lee, M.D. graduated from Wuhan Medical College in China. After a residency-fellowship at Cornell-New York Hospital and Memorial Hospital for Cancer, Dr. Lee was certified by the American Board of Pathology and obtained the F.R.C.P. (C) degree by examination in 1966. He was on the faculty of McGill University and Yale University from 1968-2004 while practicing hospital-based pathology. Dr. Lee is currently the director of Milford Molecular Diagnostics, Milford, Connecticut. In the past 10 years, Dr. Lee has developed Sanger sequencing-based testing methods for HPV, Neisseria gonorrhoeae, Chlamydia trachomatis, Lyme disease borreliae and Ebolavirus implementable in community hospitals.

Dr. Lee has developed Sanger sequencing-based testing methods for HPV, Neisseria gonorrhoeae, Chlamydia trachomatis, Lyme disease borreliae and Ebolavirus implementable in community hospitals.

Ham Benghuzzi received his Master in Chemistry and PhD in biological Sciences with concentration in physiology from University of Dayton in Ohio. In 1993, he completed postdoctoral training in pathology department at the University of Michigan Medical center. Thereafter, he joined the university of Mississippi Medical Center and currently he is professor in the department of diagnostic and clinical health sciences. He is a fellow of the American Institute of Medical and Biological Engineering, as well as, International Fellow of the World Congress of Biomaterials Societies (Japanese, American, Asian, and European). He is a pioneer scientist in ceramic drug delivery systems. His area of research is the development and applications of novel ceramic drug delivery systems (over 26 years/over 300 publications and 600 abstracts at various meetings). He served and serving as a major advisor for over 35 PhD students as well as a mentor for students at various levels (High school, undergraduate, MS, residents and postdoctoral). He received Nemours awards and honors from very prestigious societies and organizations. He was invited as a keynote speaker at state, national and international levels. His recent research was the first, worldwide, to histopathologicaly identify the role of sustained delivery of reproductive hormones in the induction of azoospermia

His recent research was the first, worldwide, to histopathologicaly identify the role of sustained delivery of reproductive hormones in the induction of azoospermia.

Merce Jorda, M.D. is board certified in American Board of Pathology-Cytopathology. Has completed her fellowship from Jackson Memorial Hospital in Affiliation with the University Of Miami School Of Medicine. Prof. Jorda is the Medical Director, Clinical Laboratory Services -UMHC/SCCC and UM Hospital. Dr. Jorda’s research interests include molecular pathology of cancer and immunocytochemistry of tumors. She is interested in all markers, immunohistochemical and molecular, which may give the diagnostic, prognostic, predictive and treatment information. Dr. Jorda’s research interests have been basically at the level of anatomic pathology and cytopathology, specifically in the areas of breast and genitourinary tract malignancies as well as cytopathology.

Merce Jorda, M.D. is board certified in American Board of Pathology-Cytopathology. Has completed her fellowship from Jackson Memorial Hospital in Affiliation with the University Of Miami School Of Medicine. Prof. Jorda is the Medical Director, Clinical Laboratory Services -UMHC/SCCC and UM Hospital. Dr. Jorda’s research interests include molecular pathology of cancer and immunocytochemistry of tumors. She is interested in all markers, immunohistochemical and molecular, which may give the diagnostic, prognostic, predictive and treatment information. Dr. Jorda’s research interests have been basically at the level of anatomic pathology and cytopathology, specifically in the areas of breast and genitourinary tract malignancies as well as cytopathology.

Laura Adhikari, MD completed her residency training at the Mayo Clinic and completed her cytopathology fellowship at Ohio State University. She is currently at the Washington University School of Medicine in St. Louis and has published many articles on endocrine pathology focusing on pancreas and thyroid cytology. Her most recent publication was a multi-institutional study of fine needle aspiration for thyroid lymphoma.

My research interest is predominantly in endocrine and cytopathology, with a specific interest in neoplasms of the pancreas.

Dr. Li is an internationally recognized expert in the field of cytopathology and co-PI in Johns Hopkins Biomarker Discovery Center. She provides diagnostic service at Johns Hopkins, and conducts research in the field of novel biomarkers in lung and prostate cancers. Her research has been presented at many national/international meetings. Dr. Li also serves as editorial board members for several journals, committee member of the American Society of Cytopathology, and study sections of government agents and private organizations. She has more than 70 publications and book chapters. Dr. Li is also the editor of “Diagnostic Cytopathology Board Review and Self-Assessment”.

She provides diagnostic service at Johns Hopkins, and conducts research in the field of novel biomarkers in lung and prostate cancers.

Dr. Taniyama completed his PhD in Pathology at the Hiroshima University School of Medicine in Japan in 1985, and he learnt molecular techniques and laser capture microdissection at the University of California, San Diego Cancer Center in 1998-99. He joined the National Hospital Organization (NHO), Kure Medical Center and Chugoku Cancer Center in 2002, and he became the president of this center in July 2014.

Molecular techniques and laser capture micro dissection.

Guo-Min Deng has obtained MD in China and PhD in Gothenburg University, Sweden in 2001. He worked as research fellow in NIH, USA during 2002-2006 and worked as instructor and assistant professor in Harvard University during 2006-2014. He is distinguished professor and the director of key Lab of antibody techniques of ministry of health in Nanjing Medical University. He has published more than 25 papers in reputed journals including Nature Medicine, Nature reviews Rheumatology and has been serving as an editorial board member of repute.

Pathogenesis and therapy of autoimmune diseases. Pathogenesis of bacterial DNA-induced inflammation

Pasquale De Blasio has completed his Master Degree in Business Administration in 1986 from Bocconi University in Milan Italy and his Bachelor of Science in Electrical Engineering in 1976 from Villanova University, Villanova Pa, USA. He founded ISENET in 1986 which operates in the field of Biobanking and Tissue Microarray Technology. He is also the Founding President of the European, Middle East and African Society for Biopreservation and Biobanking (ESBB). He has published more than 25 papers and book chapter in reputed journals and serving as an editorial board member of Biopreservation and Biobanking.

Biobanking and Tissue Microarray Technology.

Irina Shabalova has got her MD degree in Moscow Medical Institute, PhD in 1986 from Cancer Research Centre by P.N.Herzen, Sc.D. degree in 2002. Her practice as clinical cytologist begins from 1975. Positions: Unior Researcher, P.A. Herzens’Cancer Research Centre, Associate Professor, Central Institute of Postgraduated Education, Senior Researcher, N.N. Blokhin Cancer Research Centre, 2003 - Professor, Russian Medical Academy of Postgraduated Education. She has published more than 140 papers, 9 books. An editorial board member of the journals “Clinical Laboratory Diagnostics”, “Laboratory” (Russia), advisory board member of the “Cytopathology” (GB). MIAC, president of the Russian Association of Clinical Cytologists.

Her research area includes clinical cytology